Koninklijke Philips N.V. (ETR:PHI1)
Germany · Delayed Price · Currency is EUR | Market Cap | 22.34B -1.6% |
| Revenue (ttm) | 17.83B -1.0% |
| Net Income | 895.00M |
| EPS | 0.93 |
| Shares Out | n/a |
| PE Ratio | 24.96 |
| Forward PE | 15.01 |
| Dividend | 1.70 (7.25%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 6,460 |
| Average Volume | 8,384 |
| Open | 23.70 |
| Previous Close | 23.69 |
| Day's Range | 23.38 - 23.77 |
| 52-Week Range | 19.13 - 27.57 |
| Beta | 0.94 |
| RSI | 38.72 |
| Earnings Date | May 6, 2026 |
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as ... [Read more]
Financial Performance
Financial StatementsNews
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures , supporting treatment [2] DeviceGuide integrates wi...
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care...
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.
Philips convenes the Annual General Meeting of Shareholders 2026
March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM)...
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
March 23, 2026 John DeFord proposed as new member of the Supervisory Board. Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.
Speech Processing Solutions Launches Philips SpeechLive Health, an AI Assistant Built for Modern Clinical Documentation
VIENNA--(BUSINESS WIRE)-- #ambientai--Speech Processing Solutions launches Philips SpeechLive Health AI Assistant to convert clinical conversations into structured documentation.
Philips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behind
March 20th, Philips Sonicare invites New Yorkers to rethink their nightly clean with an inside look at what happens in your mouth while you sleep CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- R oya...
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite
March 11, 2026 Fully cloud ‑ enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA)...
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26
March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platfo...
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments
March 4, 2026 CE Marked and 510(k) pending, Rembra's advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to suppor...
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments
March 3, 2026 With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partners ...
Philips publishes its Annual Report 2025
February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips' Annual Report 2025 will be o...
Philips introduces InkSpace Imaging's Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort
February 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric b...
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
February 11, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the research consortium is coordinated by Philips, together with Erasmus MC as academic lead, and will combine advanced medi...
Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript
Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript
Philips Proposes Extension of CEO's Tenure After Guiding For Higher Profitability
Roy Jakobs has headed Philips since October 2022 and the company said it would put his re-appointment to shareholders later this year.
Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day
Amsterdam, February 10, 2026 Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4 Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth ...
Philips proposes to re-appoint CEO Roy Jakobs
February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its Preside...
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment
February 3, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the Philips-coordinated research consortium will combine advanced medical imaging, robotic guidance technologies, and AI to s...
Philips Receives Frost & Sullivan's 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology-Healthcare Informatics
Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics SAN ANTONIO, Jan. 29, 202...
Koninklijke Philips: Macro Set-Up Favors And AI Tailwinds
Philips benefits from sector-wide valuation tailwinds, anticipated MedTech revival in 2026, and accelerating organic revenue growth. AI integration, highlighted by the SpectraWAVE acquisition, is set ...
Kiwi Information Technology Co. Ltd. debuts Philips Home Access Solutions at Big 5 Construct Saudi 2026, deepening channel partnerships across Saudi Arabia
RIYADH, Kingdom of Saudi Arabia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Kiwi Information Technology Co. Ltd. (Kiwi) showcased Philips Home Access solutions at Big 5 Construct Saudi 2026, underscoring its c...
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026 Innovations for healthcare professionals and consumers that support bett...
Philips: Waiting Comfortably For Upside From Healthcare AI Leadership
Philips N.V. (PHG) is rated a conservative 'Buy' with a maintained price target, reflecting 20%+ annualized upside potential. PHG's leadership in imaging, healthcare AI, and a strong moat in diagnosis...
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
December 15, 2025 Acquisition of SpectraWAVE's next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside...